Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.
about
Antiretroviral interventions for preventing breast milk transmission of HIVAntiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaWhat influences feeding decisions for HIV-exposed infants in rural Kenya?Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).The role of co-infections in mother-to-child transmission of HIV.Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants.Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulationsFrequent nevirapine resistance in infants infected by HIV-1 via breastfeeding while on nevirapine prophylaxisSoluble CD14: An Independent Biomarker for the Risk of Mother-to-Child Transmission of HIV in a Setting of Preexposure and Postexposure Antiretroviral Prophylaxis.Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trialHIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana.Infant feeding buddies: a strategy to support safe infant feeding for HIV-positive mothers.Mother-to-Child Transmission of HIV and HIV-Free Survival in Swaziland: A Community-Based Household Survey.
P2860
Q22252958-0491B013-36D6-4965-B211-1AE0A4EA64A0Q27014960-1DB9484A-1BB1-4BAD-B7C6-7D553626D72AQ33901535-54691A9D-C104-458B-9507-31D85AF3CD03Q35475930-18AF5185-F18E-47B2-A285-E34569F242E0Q35542406-AD7BBEA0-18DD-4E6F-941A-749D412612FEQ35598505-8F466C94-435A-499C-8FEF-54A78223A530Q36149804-7EFF5BC4-93F0-479B-8CE0-D41EAD40D5DFQ36410952-69E37719-932E-464E-B053-C08E543379C3Q36471547-AFB07CFA-6350-41D1-877F-98268C30C513Q36562812-37141C73-1F4A-4C68-BC01-D18EFCA7A1C9Q36866309-71788589-D5AE-4701-8376-17DFB371966DQ37703445-2273A053-F9D2-4A80-98CF-552B9180409CQ43573281-46AA4684-032D-4F38-AC4B-BC062D5FDC99Q53689230-34BEECDB-8F56-41E7-ADE7-92F6A03D96FF
P2860
Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Twelve-month follow-up of Six ...... th by maternal CD4 cell count.
@en
type
label
Twelve-month follow-up of Six ...... th by maternal CD4 cell count.
@en
prefLabel
Twelve-month follow-up of Six ...... th by maternal CD4 cell count.
@en
P1433
P1476
Twelve-month follow-up of Six ...... th by maternal CD4 cell count.
@en
P2093
Six Week Extended Dose Nevirapine (SWEN) Study Team
P304
P356
10.1097/QAD.0B013E328344C12A
P407
P50
P577
2011-03-01T00:00:00Z